METROPOLIS.BO logo
BSE · METROPOLIS.BOMedical - Diagnostics & ResearchUpdated Nov 8, 2026

Metropolis Healthcare Limited P/E ratio

Current valuation, historical context, and peer comparisons.

Current P/E ratio

56.59×

4.9% abovethe 7-observation annual average

Share price569.25
÷
Earnings per share10.06

Price and EPS in quote currency. Calculation details

Investors are paying 56.59 for every 1 of reported earnings per share.

P/E over time

2020 – 2026
Annual P/ESelected-period average 53.92×
3-year average57.00×3 positive annual observations
5-year average52.90×5 positive annual observations
10-year average53.92×7 positive annual observations
Peer median · TTM51.48×6 peers with positive P/E

Historical P/E ratios

Annual period-end data · 7 observations

METROPOLIS.BO annual P/E history, newest first
Period endP/EChange
Mar 31, 202647.23×-12.8%
Mar 31, 202554.18×-22.1%
Mar 31, 202469.59×+55.0%
Mar 31, 202344.89×-7.7%
Mar 31, 202248.62×-22.0%
Mar 31, 202162.31×+23.0%
Mar 31, 202050.65×N/M

Change is relative to the preceding observation. N/M values are excluded from averages.

How METROPOLIS.BO compares

Company P/E vs. peer trailing-12-month ratios

P/E comparison with METROPOLIS.BO and provider-selected peers
CompanyP/E ratio
METROPOLIS.BO logo
METROPOLIS.BO This stockMetropolis Healthcare Limited
56.59×
LALPATHLAB.NS logo
LALPATHLAB.NSDr. Lal PathLabs Limited
56.48×
VIJAYA.NS logo
VIJAYA.NSVijaya Diagnostic Centre Limited
74.21×
THYROCARE.NS logo
THYROCARE.NSThyrocare Technologies Limited
54.49×
NIDAN.NS logo
NIDAN.NSNidan Laboratories & Healthcare Ltd.
N/M
ASPIRA.BO logo
ASPIRA.BOAspira Pathlab & Diagnostics Limited
N/M
SURAKSHA.NS logo
SURAKSHA.NSSuraksha Diagnostic Ltd.
48.48×
VIMTALABS.NS logo
VIMTALABS.NSVimta Labs Limited
27.80×
KRSNAA.NS logo
KRSNAA.NSKrsnaa Diagnostics Limited
15.71×

Peers are selected by the data provider. Business models and earnings definitions can differ.

Put the numbers in context

What does METROPOLIS.BO’s P/E tell you?

01

Start with its own history

At 56.59×, METROPOLIS.BO is 4.9% above its 7-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.

02

Compare like with like

The median of the 6 positive peer ratios above is 51.48×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.

03

Check what drives earnings

One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.

Keep your research connected

Take METROPOLIS.BO into your spreadsheet

Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.

Explore Wisesheets
Quarterly P/E · latest quarter
=WISE("METROPOLIS.BO", "PE Ratio", "LQ")
LQ selects the latest reported quarter. Requires the Wisesheets add-in. See available data

Sources & calculation methodology

Current P/E

Share price 569.25 ÷ EPS 10.06 = 56.59×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Nov 8, 2026; this is not a real-time trading quote.

History & averages

Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.

Data definitions and limitations

The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.

METROPOLIS.BO P/E ratio: common questions

The essentials behind the numbers.

Metropolis Healthcare Limited's current P/E is 56.59× based on the quote data last updated Nov 8, 2026. It represents the share price divided by reported earnings per share. Prices and earnings may refresh on different schedules.

Annual P/E uses earnings for a completed fiscal year. Trailing-12-month (TTM) P/E uses the latest four quarters, while forward P/E uses forecast earnings. These are not interchangeable. This page labels peer ratios as TTM and shows dated annual or quarterly historical observations; it does not show forward estimates.

N/M means not meaningful: the feed has no positive P/E for that observation. Negative or zero earnings should not be ranked as a low positive valuation multiple. N/M observations are excluded from the averages shown above.

Divide the share price by earnings per share (EPS). For example, a share price of 100 and EPS of 5 gives a P/E of 20×. This page uses the price and EPS supplied together in the quote when both are positive.

Price timestamps, EPS definitions, share classes, adjustments, and fiscal periods can differ. A forward P/E also uses forecast earnings rather than reported earnings. Compare the inputs and as-of dates before comparing two displayed ratios.

Not necessarily. The average describes previous market pricing, not fair value. Changes in earnings quality, growth expectations, debt, accounting, and business risk can justify a different multiple today.